Drug Trial Radar · NCT00501982
Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study
Last checked: Nov 20, 2026Latest source record: Aug 3, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
208
Actual
Start
Mar 2007
Primary completion
May 2008
Study completion May 2008
Sponsor
- Lead sponsor
- Chiesi Farmaceutici S.p.A.Industry
- Sponsor type
- Industry
- First posted
- Jul 17, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 25 weeks, up to 28 weeks
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to compare two methods of post-delivery stabilization and subsequent early respiratory care for reducing the need for MV and related secondary complications, such as BPD, in premature babies at high risk of RDS: 1. Early stabilization on nCPAP 2. Intubation, prophylactic surfactant (Curosurf®) administration shortly after delivery, and rapid extubation to nCPAP. The data obtained from this comparison will be applied to test the hypothesis that preterm neonates at risk of RDS who are treated with prophylactic surfactant + nCPAP show less need for MV when compared to infants who receive nCPAP alone.
Conditions
- Respiratory Distress Syndrome, Newborn
Interventions
Poractant alfa (Curosurf®)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Need for MVTime frame: Within the first 5 days of life
Locations
5 sites in 5 countries. Site status is shown where the registry gives one.
General Faculty Hospital
Prague, Czechia
Hopital De La Conception
Marseille, France
Ospedale Maggiore
Bologna, Italy
Maternidade Alfredo da Costa
Lisbon, Portugal
Hospital De Cruces
Bilbao, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.